Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

IMACS Group Meeting 2007


-- Joint Breakfast Meeting of the JDM Working Group and IMACS*

-- Saturday November 10, 2007; Time: 6:45 - 9:00 AM

-- Location: The Westin Boston Waterfront - Room: Commonwealth Ballroom Section A & B


Breakfast Service begins
0700 - 0745
Moderators: Drs. Bianca Lang and David Isenberg
1. Cure JM Ms. Jacquelyne DenUyl
2. The Myositis Association Mr. Bob Goldberg
3. CARRA - JDM Practice Survey Dr. Brian Feldman
4. PRINTO JDM Trial Dr. Nicola Ruperto
5. JDM Diagnostic Criteria Study Dr. Clarissa Pilkington
6. Myositis Classification Criteria Project Dr. Ingrid Lundberg
7. Etanercept for Dermatomyositis Trial Dr. Anthony Amato
8. Rituximab in Myositis (RIM) Trial Dr. Chester Oddis
9. MITAX Computer Program Dr. David Isenberg
10. IMACS Trials Repository Drs. Lisa Rider and Fred Miller
0745 - 0900
Moderators: Drs. Frederick Miller and Lisa Rider
1. Dendritic Cells in the Pathogenesis of Juvenile Dermatomyositis Dr. Ann Reed
2. Scientific Rationale for the Interferon-Alpha Blockade in DM/PM Dr. Steven Greenberg
3. Endogenous Activation of the Type I Interferon System in Myositis - A role for Anti-Jo 1 or Anti-Ro? Dr. Ingrid Lundberg
4. Interferon response in JDM vs. SLE Dr. Virginia Pascual
5. Relationship of Interferon Gene Expression to Disease Activity and Duration Dr. Lauren Pachman
6. Anti-interferon alpha as a treatment for idiopathic inflammatory myopathy Dr. Gregory Dennis

The generous support of sponsors Wyeth/Amgen, The Myositis Association and the Cure JM Foundation is appreciated.

to Top